Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Zagzag

Showing results (61-70 of 189) with videos related to

Pageof 19
Sort By:
Magnetic Resonance in Medicine|April 22, 2003
Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathologySoonmee Cha, Glyn Johnson, Youssef Zaim Wadghiri, et al.
Neurosurgery|May 26, 2006
Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomasMeng Law, Sarah Oh, Glyn Johnson, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 1, 2012
Cyst with a mural nodule tumor of the brainEytan Raz, David Zagzag, Luca Saba, et al.
Acta Neuropathologica|December 25, 2010
R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult gliomaSusan C Williams, Matthias A Karajannis, Luis Chiriboga, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|September 1, 2012
Temporal bone histopathology case of the month: Malignant peripheral nerve sheath tumor arising within vestibular schwannomaCalvin Wei, Selena E Heman-Ackah, Kia Newman, et al.
Cancer Research|March 3, 2006
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1BBalaji Krishnamachary, David Zagzag, Hideko Nagasawa, et al.
AJNR. American Journal of Neuroradiology|June 19, 2004
Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumorsMeng Law, Khuram Kazmi, Stephan Wetzel, et al.
Anti-Cancer Drugs|August 2, 2007
The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivoElizabeth W Newcomb, Yevgeniy Lukyanov, Tona Schnee, et al.
AJNR. American Journal of Neuroradiology|May 14, 2004
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma gradeMeng Law, Stanley Yang, James S Babb, et al.
Breast (Edinburgh, Scotland)|July 28, 2016
Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk predictionMei R Fu, Yvette P Conley, Deborah Axelrod, et al.
Pageof 19

Showing results (61-70 of 189) with videos related to

Sort By:
Pageof 19
Magnetic Resonance in Medicine|April 22, 2003
Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathologySoonmee Cha, Glyn Johnson, Youssef Zaim Wadghiri, et al.
Neurosurgery|May 26, 2006
Perfusion magnetic resonance imaging predicts patient outcome as an adjunct to histopathology: a second reference standard in the surgical and nonsurgical treatment of low-grade gliomasMeng Law, Sarah Oh, Glyn Johnson, et al.
Cancer Imaging : the Official Publication of the International Cancer Imaging Society|September 1, 2012
Cyst with a mural nodule tumor of the brainEytan Raz, David Zagzag, Luca Saba, et al.
Acta Neuropathologica|December 25, 2010
R132H-mutation of isocitrate dehydrogenase-1 is not sufficient for HIF-1α upregulation in adult gliomaSusan C Williams, Matthias A Karajannis, Luis Chiriboga, et al.
Otology & Neurotology : Official Publication of the American Otological Society, American Neurotology Society [And] European Academy of Otology and Neurotology|September 1, 2012
Temporal bone histopathology case of the month: Malignant peripheral nerve sheath tumor arising within vestibular schwannomaCalvin Wei, Selena E Heman-Ackah, Kia Newman, et al.
Cancer Research|March 3, 2006
Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1BBalaji Krishnamachary, David Zagzag, Hideko Nagasawa, et al.
AJNR. American Journal of Neuroradiology|June 19, 2004
Dynamic susceptibility contrast-enhanced perfusion and conventional MR imaging findings for adult patients with cerebral primitive neuroectodermal tumorsMeng Law, Khuram Kazmi, Stephan Wetzel, et al.
Anti-Cancer Drugs|August 2, 2007
The geldanamycin analogue 17-allylamino-17-demethoxygeldanamycin inhibits the growth of GL261 glioma cells in vitro and in vivoElizabeth W Newcomb, Yevgeniy Lukyanov, Tona Schnee, et al.
AJNR. American Journal of Neuroradiology|May 14, 2004
Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma gradeMeng Law, Stanley Yang, James S Babb, et al.
Breast (Edinburgh, Scotland)|July 28, 2016
Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk predictionMei R Fu, Yvette P Conley, Deborah Axelrod, et al.
Pageof 19